Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-25-050374

Options or other derivatives

  • Director acquired 3,788 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ferrante Karen Jean Director 2025-04-01 Grant or award · Stock Option (Right to Buy) +3,788 3,788 D: show line 1 in the form
Loading xslF345X05/ownership.xml…